18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR-ONC-14004780
正在进行
/
/
/
2014-06-10
/
/
Primary Open Angle Glaucoma, Primary Angle Closure Glaucoma, Ocular Hypertension
對原發性開角型青光眼、原發性閉角型青光眼或高眼壓病人施用0.0015% Tafluprost(他氟前列素)滴眼液後的24小時眼球內壓概況的研究
對原發性開角型青光眼、原發性閉角型青光眼或高眼壓病人施用0.0015% Tafluprost(他氟前列素)滴眼液後的24小時眼球內壓概況的研究
對原發性開角型青光眼、原發性閉角型青光眼或高眼壓病人施用0.0015% Tafluprost(他氟前列素)滴眼液後的24小時眼球內壓概況的研究
单臂
Ⅳ期
NA
/
Santen Pharmaceutical Co., Ltd.
/
15
/
2014-06-24
1990-01-01
/
1) Primary open angle glaucoma, primary angle closure glaucoma or ocular hypertension; 2) Above those who are currently on anti-glaucoma medication (beta-blocker, carbonic anhydrase inhibitor or their combination) and insufficiently controlled; 3) Baseline IOP is 21mmHg or higher (for PACG patient, IOP is to be 21mmHg or higher after laser iridotomy or laser iridoplasty is conducted); 4) Those who can visit the clinic on the designated day as instructed by the physician.;
登录查看1) History of intra-ocular surgery (not including laser iridotomy or laser iridoplasty conducted for PACG patients); 2) In case of primary angle closure, laser iridotomy or laser iridoplasty within one month prior to giving the informed consent is conducted; 3) Patients who are treated by prostaglandin analogues or its combinations; 4) History of drug allergy (hypersensitivity) to the drugs to be used during the study period (anesthetic ophthalmic solution, fluorescein, etc.) or similar drugs to the investigational product; 5) Presence of any corneal disorder that may interfere with accurate IOP measurement using applanation tonometry; 6) Presence of corneal disorder that may interfere with accurate 24 hour IOP measurement using contact lens device; 7) Patients who are treated by steroids.(e.g. dexamethasone, hydrocortisone sodium succinate, prednisolone acetate); 8) Female patients who are pregnant, nursing or planning a pregnancy; 9) Patients wearing glasses with metal frames; 10) Patients with severe dry eye syndrome.;
登录查看Santen Pharmaceutical Co., Ltd.
/
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
医药速览2024-11-22
亚盛医药2024-11-22